Using genomic scars to select immunotherapy beneficiaries in advanced non-small cell lung cancer

por Donker, H. C., van Es, B., Tamminga, M., Lunter, G. A., van Kempen, L. C. L. T., Schuuring, E., Hiltermann, T. J. N., Groen, H. J. M.
Publicado 2023

Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients

por El Hajj, P, Journe, F, Wiedig, M, Laios, I, Salès, F, Galibert, M-D, Van Kempen, L C, Spatz, A, Badran, B, Larsimont, D, Awada, A, Ghanem, G
Publicado 2013

SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma

por El Hajj, P, Gilot, D, Migault, M, Theunis, A, van Kempen, L C, Salés, F, Fayyad-Kazan, H, Badran, B, Larsimont, D, Awada, A, Bachelot, L, Galibert, M-D, Ghanem, G, Journe, F
Publicado 2015

Cytology of the vulva: feasibility and preliminary results of a new brush

por van den Einden, L C G, Grefte, J M M, van der Avoort, I A M, Vedder, J E M, van Kempen, L C L T, Massuger, L F A G, de Hullu, J A
Publicado 2012